Charles S. Hrushka
Overview
Charles S. Hrushka received an average of $252K in total compensation, including $94K in salary, at Pernix Therapeutics Holdings between 2011 and 2012.
Source: SEC filing on April 26, 2013.
Related executives
We found ten more executives who work or worked at Pernix Therapeutics Holdings.
Graham Miao
Pernix Therapeutics Holdings
Chief Financial Officer
John Sedor
Pernix Therapeutics Holdings
Chief Executive Officer
Kenneth Piña
Pernix Therapeutics Holdings
Secretary
Sanjay Patel
Pernix Therapeutics Holdings
Chief Financial Officer
Doug Drysdale
Pernix Therapeutics Holdings
Chief Executive Officer
Rick Shalaby
Pernix Therapeutics Holdings
Senior Vice President of Commercial Operations
Terence Novak
Pernix Therapeutics Holdings
Chief Operating Officer
David Becker
Pernix Therapeutics Holdings